Filing Flows › Celularity (CELU) › Q2 2026
Celularity (CELU) Q2 2026 earnings results (second quarter 2026)
10-Q filed Oct 20, 2026
Celularity (CELU) reported revenue of $5.4M for the second quarter 2026 (Q2 2026), -5% from a year earlier and +41% from the quarter before. Operating margin was -78.0%, net earnings $706K (13.0% of revenue).
Celularity, Q2 2026: revenue $5.4M (-5% year over year), operating margin -78.0%, net earnings $706K, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.4M | +41% | -5% |
| Operating profit | −$4.2M | — | — |
| Net earnings | $706K | -19% | — |
| Operating cash flow | −$1.1M | -177% | — |
What changed
Revenue was $5.4M in Q2 2026, down 5% year over year and up 41% from the previous quarter. Product was the largest line at 75% of revenue. License Royalty and Other lost $1.4M year over year (down 65%), 448% of the total change.
Operating costs exceeded revenue by $4.2M, an operating margin of -78.0%. Total costs fell 55% while revenue fell 5%. Net earnings were $706K. The effective tax rate was 0.0%. Non-operating items added $4.9M, 700% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$1.1M. Non-cash charges added back $1.5M of depreciation and amortization and $844K of share-based compensation. Working capital and other items used $4.2M.
Questions
What was Celularity's revenue in the second quarter 2026?
Celularity (CELU) reported revenue of $5.4M for the second quarter 2026 (Q2 2026), -5% from a year earlier and +41% from the quarter before.
Was Celularity profitable in the second quarter 2026?
Operating loss was $4.2M (-78.0% of revenue) and net earnings $706K.
Source: Celularity 10-Q on SEC EDGAR.